Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
21
TPET Quote, Financials, Valuation and Earnings
Last price:
$0.83
Seasonality move
:
-5.66%
Day range:
$0.72 - $0.81
52-week range:
$0.71 - $3.25
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
15.26x
P/B ratio:
0.59x
Volume:
777.9K
Avg. volume:
253.8K
1-year change:
-28.06%
Market cap:
$6.7M
Revenue:
$213.2K
EPS (TTM):
-$1.25
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $213.2K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | $400 | $2.8K | $2.8K | $2.8K | |
| Gross Profit | -- | -$400 | -$2.8K | -$2.8K | $210.4K | |
| Gross Profit Margin | -- | -- | -- | -- | 98.69% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $24.8K | $365.4K | $3.3M | $4.7M | |
| Other Inc / (Exp) | -- | -- | -$1.3M | -$1.1M | -$1.3M | |
| Operating Expenses | -- | $63.6K | $803.2K | $4.6M | $6.4M | |
| Operating Income | -- | -$63.9K | -$806K | -$4.6M | -$6.2M | |
| Net Interest Expenses | -- | $38.1K | $1.7M | $791.8K | $2.1M | |
| EBT. Incl. Unusual Items | -- | -$102.1K | -$3.8M | -$6.5M | -$9.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$102.1K | -$3.8M | -$6.5M | -$9.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$102.1K | -$3.8M | -$6.5M | -$9.6M | |
| Basic EPS (Cont. Ops) | -- | -$0.09 | -$3.29 | -$5.67 | -$4.32 | |
| Diluted EPS (Cont. Ops) | -- | -$0.09 | -$3.29 | -$5.67 | -$4.32 | |
| Weighted Average Basic Share | -- | $1.2M | $1.2M | $1.2M | $2.2M | |
| Weighted Average Diluted Share | -- | $1.2M | $1.2M | $1.2M | $2.2M | |
| EBITDA | -- | -$63.6K | -$803.2K | -$4.6M | -$6.2M | |
| EBIT | -- | -$64K | -$806K | -$4.6M | -$6.2M | |
| Revenue (Reported) | -- | -- | -- | -- | $213.2K | |
| Operating Income (Reported) | -- | -$63.9K | -$806K | -$4.6M | -$6.2M | |
| Operating Income (Adjusted) | -- | -$64K | -$806K | -$4.6M | -$6.2M | |
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $63.1K | $192.4K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | 205.14% | |
| Cost of Revenues | -- | $700 | $700 | $700 | $98.9K | |
| Gross Profit | -- | -$700 | -$700 | $62.4K | $93.5K | |
| Gross Profit Margin | -- | -- | -- | 98.89% | 48.6% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $168.3K | $1.2M | $1.3M | $671.7K | |
| Other Inc / (Exp) | -- | -- | -$13.1K | -$4.2K | -- | |
| Operating Expenses | -- | $171K | $2.2M | $1.6M | $768.5K | |
| Operating Income | -- | -$171.7K | -$2.2M | -$1.5M | -$675K | |
| Net Interest Expenses | -- | $485.3K | -- | $668.4K | $147.6K | |
| EBT. Incl. Unusual Items | -- | -$708.1K | -$2.2M | -$2.2M | -$1.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -$708.1K | -$2.2M | -$2.2M | -$1.4M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$708.1K | -$2.2M | -$2.2M | -$1.4M | |
| Basic EPS (Cont. Ops) | -- | -$0.61 | -$1.47 | -$0.87 | -$0.17 | |
| Diluted EPS (Cont. Ops) | -- | -$0.61 | -$1.47 | -$0.87 | -$0.17 | |
| Weighted Average Basic Share | -- | $1.2M | $1.5M | $2.5M | $8M | |
| Weighted Average Diluted Share | -- | $1.2M | $1.5M | $2.5M | $8M | |
| EBITDA | -- | -$171K | -$2.2M | -$1.5M | -$674.3K | |
| EBIT | -- | -$171.6K | -$2.2M | -$1.5M | -$675K | |
| Revenue (Reported) | -- | -- | -- | $63.1K | $192.4K | |
| Operating Income (Reported) | -- | -$171.7K | -$2.2M | -$1.5M | -$675K | |
| Operating Income (Adjusted) | -- | -$171.6K | -$2.2M | -$1.5M | -$675K | |
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | $136K | $303.7K | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | $2.8K | $2.8K | $121.4K | |
| Gross Profit | -- | -$2.1K | -$2.8K | $133.2K | $182.3K | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $270K | $2.4M | $4.8M | $3.1M | |
| Other Inc / (Exp) | -- | -$1.3M | -$1.1M | -$1.2M | -- | |
| Operating Expenses | -- | $780.3K | $3.4M | $6.3M | $4.3M | |
| Operating Income | -- | -$780.3K | -$3.4M | -$6.2M | -$4.1M | |
| Net Interest Expenses | -- | $1M | $1.4M | $1.9M | $804.4K | |
| EBT. Incl. Unusual Items | -- | -$3.1M | -$5.9M | -$9.2M | -$6.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -$5.9M | -$9.2M | -$6.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$3.2M | -$5.9M | -$9.2M | -$6.3M | |
| Basic EPS (Cont. Ops) | -- | -$2.76 | -$4.60 | -$4.77 | -$1.25 | |
| Diluted EPS (Cont. Ops) | -- | -$2.67 | -$4.60 | -$4.77 | -$1.25 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -$2.1M | -$3.4M | -$6.2M | -$4.1M | |
| EBIT | -- | -$2.1M | -$3.4M | -$6.2M | -$4.1M | |
| Revenue (Reported) | -- | -- | -- | $136K | $303.7K | |
| Operating Income (Reported) | -- | -$780.3K | -$3.4M | -$6.2M | -$4.1M | |
| Operating Income (Adjusted) | -- | -$2.1M | -$3.4M | -$6.2M | -$4.1M | |
| Period Ending | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | 2026-07-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $136K | $226.5K | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.1K | $2.1K | $2.1K | $120.7K | -- | |
| Gross Profit | -$2.1K | -$2.1K | $133.9K | $105.8K | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $104.7K | -- | -- | -- | -- | |
| Selling, General & Admin | $270K | $2.3M | $3.7M | $2.1M | -- | |
| Other Inc / (Exp) | -$1.3M | -$1.1M | -$1.2M | -$745.3K | -- | |
| Operating Expenses | $663.1K | $3.3M | $5M | $2.9M | -- | |
| Operating Income | -$665.2K | -$3.3M | -$4.9M | -$2.8M | -- | |
| Net Interest Expenses | $1M | $747K | $1.8M | $496.2K | -- | |
| EBT. Incl. Unusual Items | -$3.1M | -$5.2M | -$7.9M | -$4.6M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -$3.1M | -$5.2M | -$7.9M | -$4.6M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$3.1M | -$5.2M | -$7.9M | -$4.6M | -- | |
| Basic EPS (Cont. Ops) | -$2.67 | -$3.98 | -$3.92 | -$0.72 | -- | |
| Diluted EPS (Cont. Ops) | -$2.67 | -$3.98 | -$3.92 | -$0.72 | -- | |
| Weighted Average Basic Share | $3.5M | $3.9M | $6.1M | $20M | -- | |
| Weighted Average Diluted Share | $3.5M | $3.9M | $6.1M | $20M | -- | |
| EBITDA | -$663.1K | -$3.3M | -$4.9M | -$2.8M | -- | |
| EBIT | -$665K | -$3.3M | -$4.9M | -$2.8M | -- | |
| Revenue (Reported) | -- | -- | $136K | $226.5K | -- | |
| Operating Income (Reported) | -$665.2K | -$3.3M | -$4.9M | -$2.8M | -- | |
| Operating Income (Adjusted) | -$665K | -$3.3M | -$4.9M | -$2.8M | -- | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $78.9K | $73.6K | $1.6M | $285.9K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | $21.2K | $35K | $133.4K | $279.3K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $100K | $108.6K | $1.7M | $565.2K | |
| Property Plant And Equipment | -- | $7.5M | $5.8M | $9.9M | $11.1M | |
| Long-Term Investments | -- | $50.5K | $10K | $10K | $10K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $7.8M | $9.5M | $11.7M | $11.7M | |
| Accounts Payable | -- | $16.1K | $1.2M | $609.4K | $1M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $1.2M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | $114.9K | -- | $455K | |
| Total Current Liabilities | -- | $3.7M | $6.7M | $1.9M | $2.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $3.7M | $6.8M | $1.9M | $2.6M | |
| Common Stock | -- | $1.1K | $1.7K | $3.1K | $300 | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | $4.1M | $2.7M | $9.8M | $9.1M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $4.1M | $2.7M | $9.8M | $9.1M | |
| Total Liabilities and Equity | -- | $7.8M | $9.5M | $11.7M | $11.7M | |
| Cash and Short Terms | -- | $78.9K | $73.6K | $1.6M | $285.9K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $41.5K | $1.5M | $293.1K | $584.4K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $95.8K | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | $324.6K | $196.4K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $87.9K | $1.6M | $617.7K | $876.6K | |
| Property Plant And Equipment | -- | $5.8M | $9M | $11.1M | $12.2M | |
| Long-Term Investments | -- | $10K | $10K | $10K | $10K | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $8.8M | $11.2M | $11.7M | $13M | |
| Accounts Payable | -- | $589.7K | $819.9K | $1.4M | $1.4M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | $556.7K | -- | |
| Total Current Liabilities | -- | $5.4M | $822.7K | $3.6M | $1.6M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $5.4M | $874.1K | $3.6M | $1.6M | |
| Common Stock | -- | $1.6K | $3K | $5K | $800 | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | $3.4M | $10.3M | $8.1M | $11.4M | |
| Total Liabilities and Equity | -- | $8.8M | $11.2M | $11.7M | $13M | |
| Cash and Short Terms | -- | $41.5K | $1.5M | $293.1K | $584.4K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$102.1K | -$3.8M | -$6.5M | -$9.6M | |
| Depreciation & Amoritzation | -- | $400 | $2.8K | $2.8K | $2.8K | |
| Stock-Based Compensation | -- | -- | $6.2K | $1M | $1.5M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$258.9K | -$1.1M | -$4.4M | -$4.1M | |
| Capital Expenditures | -- | $300K | -- | $4.1M | $1.2M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$300K | -- | -$2.2M | -$1.1M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $4.8M | $2M | $3.1M | |
| Long-Term Debt Repaid | -- | -- | -$2.9M | -$1.5M | -$352.8K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$1.5M | -$1.4M | -$259.9K | |
| Cash From Financing | -- | $637.8K | $1.1M | $8.1M | $3.9M | |
| Beginning Cash (CF) | -- | $78.9K | $73.6K | $1.6M | $285.9K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $78.9K | -$5.2K | $1.5M | -$1.3M | |
| Ending Cash (CF) | -- | $157.8K | $68.4K | $3.1M | -$990K | |
| Levered Free Cash Flow | -- | -$558.9K | -$1.1M | -$8.5M | -$5.3M | |
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$708.1K | -$2.2M | -$2.2M | -$1.4M | |
| Depreciation & Amoritzation | -- | $700 | $700 | $700 | $700 | |
| Stock-Based Compensation | -- | -- | $786K | $238.3K | $96.8K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -$64.2K | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$126.4K | -$1.7M | -$607.7K | -$355.4K | |
| Capital Expenditures | -- | -- | $1.7M | $74.6K | $495.7K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$833.9K | -$119.9K | -$512.9K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | $800K | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -$81.8K | -- | -$43.8K | -- | |
| Cash From Financing | -- | -$81.8K | $1.9M | $800K | -- | |
| Beginning Cash (CF) | -- | $41.5K | $1.5M | $293.1K | $584.4K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -$208.2K | -$682.2K | $72.5K | -$872.7K | |
| Ending Cash (CF) | -- | -$166.7K | $823.8K | $365.6K | -$288.3K | |
| Levered Free Cash Flow | -- | -$126.4K | -$3.4M | -$682.3K | -$851.1K | |
| Period Ending | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$5.9M | -$9.2M | -$6.3M | |
| Depreciation & Amoritzation | -- | -- | $2.8K | $2.8K | $2.8K | |
| Stock-Based Compensation | -- | -- | $903.1K | $1.3M | $1.1M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$2.7M | -$1.9M | -$6.1M | |
| Capital Expenditures | -- | -- | $3.2M | $2M | $929K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -$1.8M | -$1.5M | -$917.9K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | $4.5M | -- | |
| Long-Term Debt Repaid | -- | -- | -$1.5M | -$2.6M | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$1.3M | -$561.1K | -- | |
| Cash From Financing | -- | -- | $6M | $2.2M | $7.2M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | $1.5M | -$1.2M | $291.3K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$5.9M | -$4M | -$7M | |
| Period Ending | 2022-07-31 | 2023-07-31 | 2024-07-31 | 2025-07-31 | 2026-07-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$3.1M | -$5.2M | -$7.9M | -$4.6M | -- | |
| Depreciation & Amoritzation | $2.1K | $2.1K | $2.1K | $2.1K | -- | |
| Stock-Based Compensation | -- | $897K | $1.2M | $702.8K | -- | |
| Change in Accounts Receivable | -- | -- | -- | -$95.8K | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$930.1K | -$2.5M | -$92.1K | -$2.1M | -- | |
| Capital Expenditures | -- | $3.2M | $1.1M | $893.2K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$1.8M | -$1.1M | -$966.5K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $4.4M | -- | $2.5M | $606K | -- | |
| Long-Term Debt Repaid | -$2.9M | -$1.5M | -$2.6M | -$788K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$1.2M | -$1M | -$210.8K | -$43.3K | -- | |
| Cash From Financing | $892.7K | $5.8M | -$38.1K | $3.3M | -- | |
| Beginning Cash (CF) | $370.1K | $3.8M | $862.4K | $4M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$37.3K | $1.4M | -$1.3M | $298.5K | -- | |
| Ending Cash (CF) | $332.7K | $5.2M | -$406.3K | $4.3M | -- | |
| Levered Free Cash Flow | -$930.1K | -$5.8M | -$1.2M | -$3M | -- | |
Get TPET Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TPET
Sector
P/E ratio
--
12.71x
PEG ratio
--
0.00x
P/B ratio
0.59x
0.97x
Price / LTM sales
15.26x
0.94x
Growth Metrics
TPET
Sector
Revenue growth
205.14%
-3.61%
Earnings growth
79.92%
-12.06%
Revenue (5-year growth)
--
4.93%
Earnings forecast
--
$0.19
Profitability
TPET
Sector
Profitability FY 2024
$210.4K
$15.7M
Return on invested capital
-56.89%
1.93%
Return on assets
-49.38%
0.77%
Return on equity
-60.58%
3.41%
Earnings Date
Last Earnings Date
Dec
24
Next Earnings Date
Dec
24
Estimated Next Earnings Date
Mar
25
Balance Sheet
TPET
Sector
Total cash
$584.4K
$10.3M
Short term investments
--
$2.6M
Total assets
$11.7M
$291.4M
Long term debt
$900
$15.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
52
ABVX alert for Dec 23
Abivax SA [ABVX] is down 0.27% over the past day.
Buy
60
ZBIO alert for Dec 23
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
